Totally, 5 × 105 cells/ml DL-BCL cells were treated for 24 h with increasing concentrations of either BDA-366/venetoclax or a single concentration of venetoclax/BDA-366 or the combination of both treatments. Afterwards, cells were pelleted by centrifugation, and incubated with Annexin V-FITC (Life Technologies, Brussels, Belgium) and 7-aminoactinomycin D (7-AAD) (Life Technologies, Brussels, Belgium) or with 2.5 µM NucviewTM 488 caspase-3 substrate (Biotium, CA, USA) for 15 or 30 min, respectively. Cell suspensions were analyzed with an Attune® Acoustic Focusing Flow Cytometer (Applied Biosystems, Brussels, Belgium). Cell death was scored by quantifying the population of Annexin V-FITC-positive and 7-AAD positive cells or by quantifying the caspase-3 positive cells. After treating the BMK cells (3000 cells/well in 384-well plate) for 24 h with BDA-366, cells were stained for 30 min with DRAQ5, TMRE and Annexin V-Alexa fluor 488. Images were taken using the Opera High Content Screen System (PerkinElmer) with ×20 air objective. Intensity and morphology features were extracted from the fluorescent images through image segmentation and analyzed using Acapella analysis software (PerkinElmer) script (available for free at http://www.andrewslab.ca). Quantitative analyses of cell death results in cell lines are from cell populations in which at least 80% of the cells were viable in control conditions.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.